News
GeoVax, Inc.: GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases ...
Hier finden Sie den kompletten Artikel: